A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
The adaptive immune system provides antigen-specific immunity with immunological memory, activating over days to weeks but generating targeted, powerful responses. Dendritic cells present antigenic peptides on MHC molecules to T lymphocytes in lymph nodes: MHC class II activates CD4⁺ helper T cells (which orchestrate the response and help activate B cells and cytotoxic T cells); MHC class I activates CD8⁺ cytotoxic T cells (which directly kill infected or cancerous cells displaying abnormal peptides). B lymphocytes, stimulated by antigen plus T helper signals, differentiate into plasma cells that secrete antigen-specific antibodies. After infection resolves, long-lived memory T and B cells persist at elevated numbers with lower activation thresholds, enabling faster and stronger secondary responses — the mechanistic basis of vaccination.
Draw two parallel response arms meeting at the CD4⁺ T helper cell: (1) cellular arm: CD4⁺ helps activate CD8⁺ CTLs → infected cell killing; (2) humoral arm: CD4⁺ helps B cells → plasma cells → antibodies. Explain why HIV is immunologically devastating by targeting CD4⁺ cells — it collapses coordination of both arms simultaneously. Then contrast primary (slow, IgM-dominant, lower magnitude) vs. secondary response (fast, IgG-dominant, much higher magnitude).
The innate immune system you've already studied is fast and non-specific — it recognizes broad molecular patterns shared by many pathogens and mounts an immediate response. Its limitation is that it cannot learn or remember individual pathogens. The adaptive immune system solves this by doing something the innate system cannot: generating antigen-specific receptors that target the precise molecular features of a particular pathogen, then building immunological memory of that encounter.
The process is initiated by dendritic cells — sentinels that bridge the two systems. When innate immunity detects infection, dendritic cells engulf pathogens in the infected tissue, process them into peptide fragments, and travel to nearby lymph nodes. There they present these peptides on MHC molecules to T lymphocytes — the central event that activates the adaptive response. MHC class II molecules (expressed on professional antigen-presenting cells) present peptides to CD4⁺ helper T cells; MHC class I molecules (expressed on virtually all nucleated cells) present peptides to CD8⁺ cytotoxic T cells. Critically, T cell activation requires both the MHC-peptide signal AND a costimulatory signal from the dendritic cell that indicates real infection is present — without this second signal, T cells become tolerant rather than activated, a safeguard against autoimmunity.
CD4⁺ helper T cells are the orchestrators of the adaptive response. They activate CD8⁺ cytotoxic T cells, which then hunt down and kill any host cell displaying a foreign peptide on MHC class I — a powerful mechanism against intracellular pathogens like viruses. Simultaneously, CD4⁺ helpers provide essential signals to B lymphocytes, enabling them to differentiate into plasma cells that mass-produce antigen-specific antibodies. Antibodies work by three mechanisms: neutralization (physically blocking pathogen entry into cells), opsonization (coating pathogens to flag them for phagocytosis), and complement activation (triggering a protein cascade that damages pathogen membranes). A common misconception is that antibodies directly destroy pathogens — in reality they tag and weaken them for elimination by other effectors.
After the infection resolves, most effector cells die, but a subset survive as long-lived memory T and B cells. These cells persist at elevated numbers with lower activation thresholds, so a second encounter with the same pathogen triggers a faster, stronger response — the secondary response. Primary responses are dominated by IgM antibodies and take one to two weeks to peak; secondary responses are dominated by higher-affinity IgG antibodies and peak within days, often clearing the pathogen before symptoms develop. This is the mechanistic basis of vaccination: exposing the immune system to antigen (without disease) to generate memory cells that protect against future infection.